Ash Annual Meeting 2024 Abstracts 2024. Disease burden and minimal residual disease in prognosis and treatment: The embargo lifts when abstracts go live november 5, 2024 at 9 a.m.

Incy) today announced that the company will present new data from across its oncology portfolio at the 2024 american society of hematology (ash) annual. 6446), a global biopharmaceutical innovator based in taiwan leveraging deep expertise and.